α1-Adrenoceptor-Gq-RhoA signaling is upregulated to increase myofibrillar Ca2+ sensitivity in failing hearts

被引:37
作者
Suematsu, N
Satoh, S
Kinugawa, S
Tsutsui, H
Hayashidani, S
Nakamura, R
Egashira, K
Makino, N
Takeshita, A
机构
[1] Kyushu Univ, Med Inst Bioregulat, Dept Bioclimatol & Med, Beppu, Oita 8740838, Japan
[2] Kyushu Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Higashi Ku, Fukuoka 8128582, Japan
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 2001年 / 281卷 / 02期
关键词
adrenergic agonists; cardiomyopathy; contractile proteins; G proteins; protein phosphorylation;
D O I
10.1152/ajpheart.2001.281.2.H637
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
alpha (1)-Adrenergic stimulation, coupled to G(q), has been shown to promote heart failure. However, the role of alpha (1)-adrenergic signaling in the regulation of myocardial contractility in failing myocardium is still poorly understood. To investigate this, we observed 1) the effect of phenylephrine on myofibrillar Ca2+ sensitivity in alpha -toxin-skinned cardiomyocytes, and 2) protein expression of G(q), RhoA, and myosin light chain phosphorylation using tachypacing-induced canine failing hearts. Phenylephrine significantly increased myofibrillar Ca2+ sensitivity in failing but not in normal cardiomyocytes. Whereas Y-27632 (Rho kinase inhibitor) blocked the phenylephrine-induced Ca2+ sensitization in the failing myocytes, calphostin C (protein kinase C inhibitor) had no effect on Ca2+ sensitization. The protein expression of G alpha (q) and RhoA and the phosphorylation level of regulatory myosin light chain significantly increased in the failing myocardium. Our results suggest that alpha (1)-adrenoceptor-G(q) signaling is upregulated in the failing myocardium to increase the myofibrillar Ca2+ sensitivity mainly through the RhoA-Rho kinase pathway rather than through the protein kinase C pathway.
引用
收藏
页码:H637 / H646
页数:10
相关论文
共 48 条
[1]   Enhanced Gαq signaling:: A common pathway mediates cardiac hypertrophy and apoptotic heart failure [J].
Adams, JW ;
Sakata, Y ;
Davis, MG ;
Sah, VP ;
Wang, YB ;
Liggett, SB ;
Chien, KR ;
Brown, JH ;
Dorn, GW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (17) :10140-10145
[2]   Myosin light chain kinase mediates sarcomere organization during cardiac hypertrophy in vitro [J].
Aoki, H ;
Sadoshima, J ;
Izumo, S .
NATURE MEDICINE, 2000, 6 (02) :183-188
[3]   Angiotensin II activates RhoA in cardiac myocytes - A critical role of RhoA in angiotensin II-induced premyofibril formation [J].
Aoki, H ;
Izumo, S ;
Sadoshima, J .
CIRCULATION RESEARCH, 1998, 82 (06) :666-676
[4]  
BOKOCH GM, 1994, J BIOL CHEM, V269, P31674
[5]   DYSFUNCTION OF THE BETA-ADRENERGIC AND ALPHA-ADRENERGIC SYSTEMS IN A MODEL OF CONGESTIVE-HEART-FAILURE - THE PACING-OVERDRIVE DOG [J].
CALDERONE, A ;
BOUVIER, M ;
LI, K ;
JUNEAU, C ;
DECHAMPLAIN, J ;
ROULEAU, JL .
CIRCULATION RESEARCH, 1991, 69 (02) :332-343
[6]   PROTEIN-KINASE-C ENHANCES MYOSIN LIGHT-CHAIN KINASE EFFECTS ON FORCE DEVELOPMENT AND ATPASE ACTIVITY IN RAT SINGLE SKINNED CARDIAC-CELLS [J].
CLEMENT, O ;
PUCEAT, M ;
WALSH, MP ;
VASSORT, G .
BIOCHEMICAL JOURNAL, 1992, 285 :311-317
[7]   CONTRACTILE PROPERTIES AND CA-2+ RELEASE ACTIVITY OF THE SARCOPLASMIC-RETICULUM IN DILATED CARDIOMYOPATHY [J].
DAGNOLO, A ;
LUCIANI, GB ;
MAZZUCCO, A ;
GALLUCCI, V ;
SALVIATI, G .
CIRCULATION, 1992, 85 (02) :518-525
[8]  
Davies CH, 1996, EUR HEART J, V17, P189
[9]   THE EFFECTS OF VARIOUS DRUGS ON THE MYOCARDIAL INOTROPIC RESPONSE [J].
ENDOH, M .
GENERAL PHARMACOLOGY, 1995, 26 (01) :1-31
[10]   ACTIONS OF SYMPATHOMIMETIC AMINES ON THE CA-2+ TRANSIENTS AND CONTRACTIONS OF RABBIT MYOCARDIUM - RECIPROCAL CHANGES IN MYOFIBRILLAR RESPONSIVENESS TO CA-2+ MEDIATED THROUGH ALPHA-ADRENOCEPTORS AND BETA-ADRENOCEPTORS [J].
ENDOH, M ;
BLINKS, JR .
CIRCULATION RESEARCH, 1988, 62 (02) :247-265